Originally Published MX March/April 2004
BUSINESS NEWS
Express Stent Set for JapanBoston Scientific Corp. (Natick, MA) announced that it received approval from the Japanese Ministry of Health, Labor, and Welfare to market its Express2 coronary stent system. The company plans to launch the product in Japan in early 2004. The product was launched in 2002 in Europe and other global markets.
In December, Edwards Lifesciences Corp. (Irvine, CA) entered into an agreement to acquire Percutaneous Valve Technologies Inc. (Fort Lee, NJ) for $125 million. Edwards Lifesciences develops minimally invasive alternatives for patients with heart valve disease.
St. Jude Medical Inc. (St. Paul, MN) submitted its final module and report from its resynchronization hemodynamic treatment for heart failure management implantable cardioverter- defibrillator study to FDA. The submission supports St. Jude's premarket approval applications for multiple cardiovascular devices.
Abbott Laboratories (Abbott Park, IL) announced that it will name its spin-off hospital products company Hospira. The new company, to be launched in the first half of this year, will have estimated worldwide sales of $2.5 billion and more than 14,000 employees. Christopher B. Begley will become CEO of the new company.
Copyright ©2004 MX
